Astrocyte innate immune activation and injury amplification following experimental focal cerebral ischemia
Neurochemistry International, ISSN: 0197-0186, Vol: 162, Page: 105456
2023
- 5Citations
- 3Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- Captures3
- Readers3
- Mentions1
- News Mentions1
- News1
Most Recent News
New Findings on Brain Ischemia Described by Investigators at University of Wisconsin (Astrocyte Innate Immune Activation and Injury Amplification Following Experimental Focal Cerebral Ischemia)
2023 APR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Daily -- A new study on Central Nervous System Diseases
Review Description
Astrocytes are a distinct population of glial cells responsible for many homeostatic functions in normal neural architecture. In the healthy brain, astrocyte functions range from maintenance of the blood brain barrier to modulation of synaptic transmission and neuronal plasticity to glial scar formation post-ischemic injury. In humans, this group of cells exhibits far greater heterogeneity than previously thought-with distinct subpopulations that likely carry out specialized functions. Following ischemic injury, astrocytes take on a distinct phenotype-known as the reactive astrocyte. This phenotype is responsible for both the propagation and amelioration of neuronal injury during ischemia. Following ischemia, astrocytes undergo temporal and spatial-dependent changes in morphology, gene expression, hypertrophy and hyperplasia as a result of signaling within the local microenvironment of the penumbra compared to the core infarct. This elicits a cascade of downstream effects, including inflammation and activation of the innate immune system, which both propagates and ameliorates local injury within the brain parenchyma. This review will focus upon the double-edged sword-that are astrocytes and the innate immune system. We will discuss the role that astrocytes and the innate immune system play in amplifying secondary brain injury, as well as attenuating ischemic damage. Specifically, we will focus on molecular signaling and processes that could be targeted as potential therapeutic interventions.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0197018622001814; http://dx.doi.org/10.1016/j.neuint.2022.105456; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85144389433&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36509233; https://linkinghub.elsevier.com/retrieve/pii/S0197018622001814; https://dx.doi.org/10.1016/j.neuint.2022.105456
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know